Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 4.6% - Here's WhyMarket Beat·1 hour agoAAPG-3.33%HSBC+1.22%
AstraZeneca’s US tilt could be the death knell for London’s stock marketThe telegraph·1 hour agoAZN-6.52%AZN
AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focusbenzinga_article·2 hours agoBMY+0.22%AZN-6.52%
Yen Intervention And Falling Oil Help Stocks, But Selling In Korea Throws A Monkey Wrenchbenzinga_article·2 hours agoBMY+0.22%MU+0.15%
Investors Buy Large Volume of Call Options on Astrazeneca (NYSE:AZN)Market Beat·3 hours agoAZN-6.52%BMY+0.22%
HSBC buys 2,237 Exail shares at EUR 124.63 during takeover offer filingsPUBT·3 hours agoHSBC+1.22%HSBH+1.48%
AstraZeneca PLC Stock (AZN) Moved Down by 8.54% on Aug 3: Key Drivers UnveiledTradingKey·4 hours agoAZN-6.52%AZN
AstraZeneca shares slump after $400bn BMS merger rumoursPharmaceutical Technology·4 hours agoAZN-6.52%AZN
AstraZeneca admits 8,855 new ordinary shares to London Stock Exchange main marketPUBT·4 hours agoAZN-6.52%AZN
Bristol Myers Squibb (NYSE:BMY) Sets New 12-Month High After Analyst UpgradeMarket Beat·5 hours agoBMY+0.22%AZN-6.52%
CGEN: Strong clinical progress and financial stability, with key trials and partnerships advancingQuartr·6 hours agoCGEN-2.13%GILD+5.00%
AIM ImmunoTech completes last dosing in Phase 2 DURIPANC trial of Ampligen plus AstraZeneca Imfinzi in metastatic pancreatic cancerPUBT·6 hours agoAIM+1.77%AZN-6.52%
AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Sessionbenzinga_article·7 hours agoAPMD+4.74%KOS-5.76%
